Our Strength
Research & Development Lab
Our R & D located at Mumbai is i nspected by Indian
FDA & received test license for development of more
than 50 pellet & directly compressible granule .
The lab is equipped with GMP scale down manufacturing
equipments and latest analytical instruments
This department concerns itself with following prime
OBJECTIVES
- For customer development of conventional and new sustained
release dosage forms, formulations for toxicity studies,
stability studies, dossier development +technology transfer
for customer
- For company technology transfer to the production
facility.
- The department provides the pharmaceutical support
during various stages of New Drug delivery Programmes
of our customers and in process trouble shooting .
- Reengineer process against existing patent s
- Find new drug delivery route ,Cost control , develop
analytical methods , Stability data , technology transfer
through QA
ACHIEVEMENTS
- R & D inspected by Indian FDA & received test
license for more than 50 pellet products
- Novel manufacturing process for Tamsulosin SR pellets,
Omeprazole EC pellets & Aspirin E C pellets for
tablet compression
- New drug delivery form for Oxybutynine chloride
- Developed in house assay & dissolution method
for Tamsulsoin HCL pellets & Oxybutynine pellets
The facilities exist for:
» Laboratory
Scale Development
» Pilot Scale
Development
Development of sustained release products is achieved
using following technologies:
» Rotary Spray
» Extrusions
Spheronization 
» Micro encapsulation
» Pelletization
with
» Powder drug
Coating
» Wuster Air
Suspension Coating
Major Activities :
The major activities of the department involve development
of diverse range of formulations of potential molecules.
Formulation Development activities are as follows:
- Pre-formulation Studies
- Developmental batches
- Trial Batches
- Container closure system
- Analytical Methods and their validation
- Stability Studies
- DMF
- Technology Transfer
- Batch Scale-Up
|
